To better understand the importance of patient education of molecular testing for targeted therapies, Celerity Education conducted a study to demonstrate the impact just a small amount of education can have on patient understanding of molecular testing. 

In a baseline poll, over 71% of people reported having been a caregiver for a close friend or family member with cancer. Despite a 71% familiarity with cancer over 67% of people reported that they were not familiar with genetic testing.

67.57%   

Not Familiar 

23.42%   

Somewhat Familiar

50%

25%

9.01%  

Very Familiar

0%

How familiar are you with molecular testing?

If you or a family member had cancer, how likely would you be to pay for molecular testing of the cancer?

23.08%   

Very Likely 

24.89%   

Likely 

25%

47.06% 

Maybe

24.89% 

Not Likely

50%

0%